EYECARE: Coronavirus BRIEFING: Crisis Response Tactics FDA OKs Updated COVID Vaccines By Staff Friday, August 23, 2024 6:09 AM The FDA approved and granted emergency use authorizationopens in a new tab or window for updated 2024-2025 mRNA COVID-19 vaccines from Moderna (Spikevax) and Pfizer-BioNTech (Comirnaty), the agency announced on Thursday.The new vaccines, authorized in adults and kids 6 months and up, will target the KP.2 strain of SARS-CoV-2 to more closely align with currently circulating variants, the agency said."Vaccination continues to be the cornerstone of COVID-19 prevention," Peter Marks, MD, PhD, director of FDA's Center for Biologics Evaluation and Research, said in a statement. "Given waning immunity of the population from previous exposure to the virus and from prior vaccination, we strongly encourage those who are eligible to consider receiving an updated COVID-19 vaccine to provide better protection against currently circulating variants." Head over to MedPage Today to read more about it.